Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Rheumatol Int ; 41(8): 1509-1514, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-34091704

RESUMEN

A 77-year-old man with past medical history of granulomatosis with polyangiitis (GPA) on rituximab and prednisone, presented to the hospital with worsening cough and shortness of breath. He had tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by nasal swab polymerase chain reaction (PCR) while asymptomatic, 6 weeks earlier. He started with cough and shortness of breath 2 weeks after his initial positive test. After developing symptoms, he tested negative twice by nasal swab PCR, but the PCR of his bronchioloalveolar lavage was positive for SARS-CoV-2. He did not develop antibodies against coronavirus. Prednisone 15 mg daily was continued, and he received remdesivir, and convalescent plasma with quick recovery. We reviewed the literature to search for similar cases. Our case suggests that SARS-CoV-2 infection in patients on rituximab may have an atypical presentation and the diagnosis may be delayed due to negative PCR testing in the nasal swab. Patients may benefit from treatment with convalescent plasma.


Asunto(s)
COVID-19/virología , Granulomatosis con Poliangitis/tratamiento farmacológico , Inmunosupresores/efectos adversos , Rituximab/efectos adversos , SARS-CoV-2/patogenicidad , Anciano , COVID-19/diagnóstico , COVID-19/inmunología , COVID-19/terapia , Granulomatosis con Poliangitis/diagnóstico , Granulomatosis con Poliangitis/inmunología , Interacciones Huésped-Patógeno , Humanos , Inmunización Pasiva , Huésped Inmunocomprometido , Masculino , SARS-CoV-2/inmunología , Resultado del Tratamiento , Tratamiento Farmacológico de COVID-19 , Sueroterapia para COVID-19
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA